Eli Lilly stock edges higher as company plans nearly $4 billion in vaccine deals

​ The deals are part of Eli Lilly’s effort to expand into infectious disease research and development. Read More

​ The deals are part of Eli Lilly’s effort to expand into infectious disease research and development. Read More

Leave a Reply

Your email address will not be published. Required fields are marked *

Trending now

Chamber names 2025 Small Business of the Year Award recipients – Wausau Pilot & Review
I’ve Seen 25 Years of Change in My Career — These 3 Lessons Every Business Owner Should Know
Harvard’s bold stand against Trump’s bullying
Trump administration demands foreign funding records from Harvard